FIELD: chemistry; pharmaceutics; medicine.
SUBSTANCE: invention refers to biochemistry, pharmaceutics, medicine, namely to application of enisamium iodide for reduction of inflammatory reactions. Disclosed is the use of a composition comprising an active substance enisamium iodide in an effective amount, for blocking oxidative activity of macrophages, by acting on enzymes stimulating superoxide dismutase and inhibiting NO-synthase.
EFFECT: invention provides inhibition of inflammatory reactions.
1 cl, 17 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF USING COMPOSITION CONTAINING ACTIVE SUBSTANCE ENISAMIUM IODIDE | 2023 |
|
RU2827810C1 |
| APPLICATION OF COMPOSITION CONTAINING ENISAMIUM IODIDE AS ACTIVE INGREDIENT | 2022 |
|
RU2815779C1 |
| USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
| USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2630574C2 |
| METHOD OF MODULATION OF EICOSANOID METABOLISM | 2006 |
|
RU2438684C2 |
| SOLUTIONS AND METHODS FOR INHIBITING PAIN, CARTILAGE INFLAMMATION AND DESTRUCTION | 2000 |
|
RU2271825C2 |
| PROSTAGLANDIN/CYCLOOXYGENASE PATHWAY MODULATION | 2007 |
|
RU2448712C2 |
| NOVEL APPLICATION | 2010 |
|
RU2530567C2 |
| TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
| SECRETOME ACTIVITY ANALYSIS | 2018 |
|
RU2790567C2 |
